A detailed history of 9258 Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, 9258 Wealth Management, LLC holds 215 shares of REGN stock, worth $180,213. This represents 0.04% of its overall portfolio holdings.

Number of Shares
215
Previous 215 -0.0%
Holding current value
$180,213
Previous $206,000 9.22%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$902.69 - $993.35 $194,078 - $213,570
215 New
215 $206,000
Q2 2022

Aug 04, 2022

SELL
$548.35 - $738.84 $172,730 - $232,734
-315 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $187,462 - $220,005
315 New
315 $220,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $89.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track 9258 Wealth Management, LLC Portfolio

Follow 9258 Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 9258 Wealth Management, LLC with notifications on news.